Association of Germline Variation in CCNE1 and CDK2 with Breast Cancer Risk, Progression and Survival among Chinese Han Women

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Han, Ji Yuan ^a   Wang, Hui ^a   Xie, Yun Tao ^b   Li, Yan ^a   Zheng, Li Yuan ^a   Ruan, Yuan ^a   Song, Ai Ping ^a   Tian, Xin Xia ^a   Fang, Wei Gang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E; CYCLIN E1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CCNE1 GENE; CDK2 GENE; CHINESE; CHINESE HAN; CONTROLLED STUDY; DOSE RESPONSE; EVENT FREE SURVIVAL; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; TUMOR VOLUME;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; DISEASE PROGRESSION; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GERM CELLS; HAPLOTYPES; HUMANS; KAPLAN-MEIER ESTIMATE; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84869756260     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049296     Document Type: Article

References (39)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer.
2. Turnbull C, Rahman N, (2008) Genetic predisposition to breast cancer: past, present, and future. Annu Rev Genomics Hum Genet 9: 321-345.
3. Schork NJ, Murray SS, Frazer KA, Topol EJ, (2009) Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19: 212-219.
4. The 1000 Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
5. Ghoussaini M, Pharoah PD, (2009) Polygenic susceptibility to breast cancer: current state-of-the-art. Future Oncol 5: 689-701.
6. Narod SA, (2011) Genetic variants associated with breast-cancer risk. Lancet Oncol 12: 415-416.
7. Peng S, Lu B, Ruan W, Zhu Y, Sheng H, et al. (2011) Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Breast Cancer Res Treat 127: 309-324.
8. Wall JD, Pritchard JK, (2003) Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet 4: 587-597.
9. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74: 106-120.
10. Zhao H, Pfeiffer R, Gail MH, (2003) Haplotype analysis in population genetics and association studies. Pharmacogenomics 4: 171-178.
11. Moroy T, Geisen C, (2004) Cyclin E. Int J Biochem Cell Biol 36: 1424-1439.
12. Spruck CH, Won KA, Reed SI, (1999) Deregulated cyclin E induces chromosome instability. Nature 401: 297-300.
13. Hwang HC, Clurman BE, (2005) Cyclin E in normal and neoplastic cell cycles. Oncogene 24: 2776-2786.
14. Shaye A, Sahin A, Hao Q, Hunt K, Keyomarsi K, et al. (2009) Cyclin E deregulation is an early event in the development of breast cancer. Breast Cancer Res Treat 115: 651-659.
15. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, et al. (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54: 380-385.
16. Yasmeen A, Berdel WE, Serve H, Muller-Tidow C, (2003) E- and A-type cyclins as markers for cancer diagnosis and prognosis. Expert Rev Mol Diagn 3: 617-633.
17. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, et al. (2002) Cyclin E and survival in patients with breast cancer. N Engl J Med 347: 1566-1575.
18. Scaltriti M, Eichhorn PJ, Cortes J, Prudkin L, Aura C, et al. (2011) Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients. Proc Natl Acad Sci U S A 108: 3761-3766.
19. Mittendorf EA, Liu Y, Tucker SL, McKenzie T, Qiao N, et al. (2010) A novel interaction between HER2/neu and cyclin E in breast cancer. Oncogene 29: 3896-3907.
20. Liang Y, Gao H, Lin SY, Goss JA, Brunicardi FC, et al. (2010) siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model. PLoS One 5: e12860.
21. Yin J, Lu C, Gu J, Lippman SM, Hildebrandt MA, et al. (2011) Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer. Carcinogenesis 32: 1867-1871.
22. Azzato EM, Driver KE, Lesueur F, Shah M, Greenberg D, et al. (2008) Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort. Breast Cancer Res 10: R47.
23. Cai H, Xiang YB, Qu S, Long J, Cai Q, et al. (2011) Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women. Am J Epidemiol 173: 1263-1271.
24. Cunningham JM, Vierkant RA, Sellers TA, Phelan C, Rider DN, et al. (2009) Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. Br J Cancer 101: 1461-1468.
25. Driver KE, Song H, Lesueur F, Ahmed S, Barbosa-Morais NL, et al. (2008) Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis 29: 333-341.
26. Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, et al. (2007) Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 67: 3027-3035.
27. Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Phelan CM, et al. (2009) Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 18: 935-944.
28. Song H, Hogdall E, Ramus SJ, Dicioccio RA, Hogdall C, et al. (2008) Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Clin Cancer Res 14: 1090-1095.
29. Hosgood HR, Menashe I, Shen M, Yeager M, Yuenger J, et al. (2008) Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis 29: 1938-1943.
30. Ye Y, Yang H, Grossman HB, Dinney C, Wu X, et al. (2008) Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Cancer 112: 2467-2474.
31. Berulava T, Horsthemke B, (2010) The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. Eur J Hum Genet 18: 1054-1056.
32. Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM, (2007) Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer Res 67: 9609-9612.
33. Olson JE, Wang X, Pankratz VS, Fredericksen ZS, Vachon CM, et al. (2011) Centrosome-related genes, genetic variation, and risk of breast cancer. Breast Cancer Res Treat 125: 221-228.
34. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, et al. (2010) A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 42: 978-984.
35. Varadi V, Bevier M, Grzybowska E, Johansson R, Enquist K, et al. (2011) Genetic variation in genes encoding for polymerase zeta subunits associates with breast cancer risk, tumour characteristics and survival. Breast Cancer Res Treat 129: 235-245.
36. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
37. Ruan Y, Song AP, Wang H, Xie YT, Han JY, et al. (2011) Genetic polymorphisms in AURKA and BRCA1 are associated with breast cancer susceptibility in a Chinese Han population. J Pathol 225: 535-543.
38. Ding SL, Yu JC, Chen ST, Hsu GC, Kuo SJ, et al. (2009) Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. Carcinogenesis 30: 43-49.
39. Lewis CM, (2002) Genetic association studies: design, analysis and interpretation. Brief Bioinform 3: 146-153.